Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 2196.HK Stock
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Price Chart
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 2196.HK Financial and Trading Overview
Contents
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Price Chart
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 2196.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Q&A For Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. stock price | 12.98 HKD |
| Previous Close | 21.1 HKD |
| Open | 21.1 HKD |
| Bid | 21.55 HKD x 0 |
| Ask | 21.6 HKD x 0 |
| Day's Range | 21.1 - 21.7 HKD |
| 52 Week Range | 17.36 - 34 HKD |
| Volume | 1.91M HKD |
| Avg. Volume | 2.2M HKD |
| Market Cap | 84.9B HKD |
| Beta (5Y Monthly) | 0.800342 |
| PE Ratio (TTM) | 12.134831 |
| EPS (TTM) | 0.81 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | June 8, 2022 |
| 1y Target Est | 32.19 HKD |
2196.HK Valuation Measures
| Enterprise Value | 79.42B HKD |
| Trailing P/E | 12.134831 |
| Forward P/E | 9.35065 |
| PEG Ratio (5 yr expected) | 3.01 |
| Price/Sales (ttm) | 1.9105691 |
| Price/Book (mrq) | 1.2715607 |
| Enterprise Value/Revenue | 1.787 |
| Enterprise Value/EBITDA | 13.462 |
Trading Information
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.800342 |
| 52-Week Change | -29.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 34 HKD |
| 52 Week Low | 17.36 HKD |
| 50-Day Moving Average | 22.07 HKD |
| 200-Day Moving Average | 22.92 HKD |
2196.HK Share Statistics
| Avg. Volume (3 month) | 2.2M HKD |
| Avg. Daily Volume (10-Days) | 1.65M HKD |
| Shares Outstanding | 551.94M |
| Float | 1.7B |
| Short Ratio | N/A |
| % Held by Insiders | 0.079% |
| % Held by Institutions | 34.91% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.42 |
| Trailing Annual Dividend Yield | 1.99% |
| 5 Year Average Dividend Yield | 171.00% |
| Payout Ratio | 0.348 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 9.58% |
| Operating Margin (ttm) | 8.23% |
| Gross Margin | 48.94% |
| EBITDA Margin | 13.27% |
Management Effectiveness
| Return on Assets (ttm) | 2.25% |
| Return on Equity (ttm) | 8.61% |
Income Statement
| Revenue (ttm) | 44.44B HKD |
| Revenue Per Share (ttm) | 16.83 HKD |
| Quarterly Revenue Growth (yoy) | 4.70% |
| Gross Profit (ttm) | 20.7B HKD |
| EBITDA | 5.9B HKD |
| Net Income Avi to Common (ttm) | 4.26B HKD |
| Diluted EPS (ttm) | 1.78 |
| Quarterly Earnings Growth (yoy) | 116.19% |
Balance Sheet
| Total Cash (mrq) | 16.06B HKD |
| Total Cash Per Share (mrq) | 6.01 HKD |
| Total Debt (mrq) | 30.78B HKD |
| Total Debt/Equity (mrq) | 55.92 HKD |
| Current Ratio (mrq) | 1.084 |
| Book Value Per Share (mrq) | 16.987 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.24B HKD |
| Levered Free Cash Flow (ttm) | -2902058240 HKD |
Profile of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| Country | Hong Kong |
| State | N/A |
| City | Shanghai |
| Address | Building A |
| ZIP | 200233 |
| Phone | 86 21 3398 7000 |
| Website | https://www.fosunpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 38399 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary, and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Q&A For Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
What is a current 2196.HK stock price?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 2196.HK stock price today per share is 12.98 HKD.
How to purchase Shanghai Fosun Pharmaceutical (Group) Co., Ltd. stock?
You can buy 2196.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.?
The stock symbol or ticker of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is 2196.HK.
Which industry does the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. company belong to?
The Shanghai Fosun Pharmaceutical (Group) Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have in circulation?
The max supply of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. shares is 4.69B.
What is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. PE Ratio is 16.02469000 now.
What was Shanghai Fosun Pharmaceutical (Group) Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. EPS is 0.81 HKD over the trailing 12 months.
Which sector does the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. company belong to?
The Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sector is Healthcare.